Next Article in Journal
Personalized Neuromodulation: A Novel Strategy for Improving Tinnitus Treatment
Next Article in Special Issue
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review
Previous Article in Journal
Cardiovascular Disease in Diabetes and Chronic Kidney Disease
Previous Article in Special Issue
When Do Korsakoff Patients Justify Immoral Behaviors? The Influence of Premorbid Delinquency and Self-Other Perspectives in Moral Decision-Making and Moral Reasoning
 
 
Review
Peer-Review Record

Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction

J. Clin. Med. 2023, 12(22), 6985; https://doi.org/10.3390/jcm12226985
by Claudio Brasso *, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Marco Giuseppe Alberto Nobili, Rodolfo Sgro and Paola Rocca
Reviewer 1:
Reviewer 3:
Reviewer 4: Anonymous
J. Clin. Med. 2023, 12(22), 6985; https://doi.org/10.3390/jcm12226985
Submission received: 12 September 2023 / Revised: 6 November 2023 / Accepted: 6 November 2023 / Published: 8 November 2023
(This article belongs to the Special Issue Diagnosis, Treatment, and Prognosis of Neuropsychiatric Disorders)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

This manuscript entitled “Second generation long-acting injectable antipsychotics in schizophrenia: patient’s subjective quality of life, well-being, and satisfaction” points out a very important factor in delivering quality of care to patients with schizophrenia.

This is an important manuscript that brings together a plethora of information that highlights the need for more studies in this area, just as the authors recount.

This manuscript is well-written and their tables are very accessible. I have very little to add other than a few minor points.

It seems that the title of point 3.1 is missing.

I also believe that choosing to add the methods section in between their discussion and conclusions is unusual and even disruptive for the flow of the manuscript.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

Comments and Suggestions for Authors

The problem which is discussed in the manuscript provides rather unexpected but important form clinical point of view angle. The quality of the data is very good.  The only remark – concentration of information is high and may be difficult to follow. Probably it worth to reorganize the in discussion section and to summarize separately   rather objective quality of life data and rather subjective data on well-being.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

Comments and Suggestions for Authors

The present paper describes current evidence on the efficacy of second generation long-acting (SGA-LAI) antipsychotic regimen to improve subjective quality of life, well-being, and satisfaction in patients with schizophrenia. The studies evaluated include all possible molecules administered as SGA-LAI, proposing both recent and older studies The results described suggested that the evidence is still limited because of the lack of studies on this issue and because of several methodological issues including the study design, the samples of the studies, the number of studies for each drug and dosage employed, and the variegated assessment of the subjective quality of life, satisfaction, and well-being. Although the proposed results are limited by these issues, it is important that review studies such as this one highlight the role of SGA-LAI in improving the parameters of quality of life, well-being, and satisfaction and this must push clinicians to propose these treatments with greater emphasis.

The methodology is clear and adequate. The results are very exhaustive. The idea to summarize the assessment tools for quality of life, well-being, and satisfaction makes it much easier to read the results of the individual studies included. The discussion summarizes very well the strengths and weaknesses of the current literature evidence.

 

I have only a minor request. Altrought it is not necessary to realize a risk of bias analysis (RoB) for rapid reviews, as the authors reported to have analyzed this aspect, I suggest to add a figure describing RoB and to explain the results of ROB in the main text. Which tool has been applied to RoB Assessment?

 

 

Very minor points:

Line 86-89 grammar check required

 

Line 289: grammar check required

 

Line 400: this sentence is not linked to the context

 

Line 515: grammar check required

 

Lines 553-560: results of the presented study are not described in the main text but only in the table. Please describe them also in the text to be in line with the other cited studies.

Comments on the Quality of English Language

minor checks are required

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 4 Report

Comments and Suggestions for Authors

It is clear that the authors have spent considerable time in rewriting their manuscript for which they are to be commended. Abstract: write it in an impersonal way. Figures are very limited. Also, check all the acronyms carefully, since some of them do not have their description. For a more fluid reading of the article, add the methodology after the introduction. Since its a review article, all these are very important for the readers to understand better.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop